RE: 5x current valuation due for starters12 Jan 2023 23:38
It’s quite normal for pharmas to raise funds until they get product to market at that point it’s partnerships and licensing deals which AGL are in the process of. The year has just begun so plenty of time for that before needing money at hopefully a higher price. You’d imagine any raise would come towards the end of the year or early next.
Yes IIs have sold but an II also bought, if there was an imminent raise they would’ve waited for the funding round, but no they’re smart enough to see that Parsortix is world class, maybe you should do some research beyond the ‘no cash so placing soon’ rubbish.
All IMO